The best health and wellness news from Washington state

Provided by AGP

Healthy Living Washington: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Washington.

Press releases published on May 14, 2026

Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program
GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline
Biogen Completes Acquisition of Apellis Pharmaceuticals
20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026
Biodexa issues letter to Shareholders
Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
Dogwood Therapeutics Announces First Quarter 2026 Financial Results
FDA Approves New Dosing Option for CRYSVITA® (burosumab-twza) in Adults With XLH
Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans
GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors
Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026
CapeHaven Completes First Close of Funding and Initiates Operations to Encourage Yale’s Biotech Spinouts
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Responds to BBB Challenge with Next-Gen Drug-Delivery Platform
SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Developing Distinct Next-Gen GLP-1 Built Around Novel Peptide
MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Harnesses Key AI, Voice Analysis to Offer Impairment Solution
Vor Bio Announces Publication of Interim Analysis of TELIGAN, a China Phase 3 Trial of Telitacicept in IgA Nephropathy, in The New England Journal of Medicine
Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8
OrganOx Announces Appointment of Naoya Iwata as CEO & President
INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's Disease

Share us

on your social networks:

Sign up for:

Healthy Living Washington

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.